## Abstract ## BACKGROUND The treatment of breast cancer requires a multidisciplinary approach, and patients are often referred to a multidisciplinary cancer clinic. The purpose of the current study was to evaluate the impact of this approach on the surgical management of breast cancer. ## METHOD
Multidisciplinary frontiers in breast cancer management : A surgeon's perspective
β Scribed by S. Eva Singletary
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 127 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The current paradigm of breast cancer management may be altered significantly over the coming years by the adoption of new treatment schema and devices outside of the surgical arena. New advances in breast cancer imaging will improve our ability to detect earlyβstage disease but also will assist in monitoring treatment outcomes and support the development of nonsurgical ablation techniques. These advances, some already in use, include a 3βdimensional adaptation of digital mammography, color Doppler ultrasonography that can visualize neovascularization in growing tumors, contrastβenhanced magnetic resonance imaging with improved accuracy for the detection of occult cancers, a specialized approach to positron emission tomography designed for use on the breast, and the development of nanoparticle contrast agents that can be visualized with nearβinfrared light. Systemic therapy, which revolutionized breast cancer management in the last half of the 20th century, is being reconceptualized, with attention turning to adjusting the timing of chemotherapy. Doseβdense regimens are being tested, and there also is interest in soβcalled metronomic chemotherapy in which very low doses are given on a very frequent schedule, resulting in reduced toxicity and treatment outcomes that reflect an antiangiogenic mode of action. Finally, the possibility of a breast cancer vaccine continues to intrigue and excite physicians and patients alike, with the promise of enlisting the body's own immune system to seek out and destroy cancer cells and/or prevent the development of future disease. It will be important for surgeons to stay aware of all developments that may improve the care of their patients and to be true surgical oncologists rather than merely surgical technicians. Cancer 2007. Β© 2007 American Cancer Society.
π SIMILAR VOLUMES
Two classes of inherited susceptibility genes may be considered in the etiology of breast and other common cancers. First, genes have been identified that confer a high degree of breast cancer (BC) risk, usually associated with hereditary syndromes, but disease-associated germline variants in these